Nectar Lifescience Ltd (NECLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 216478, "name": "Nectar Lifesci.", "stock_name": "Nectar Lifesci.", "full_name": "Nectar Lifescience Ltd", "name_url": "stocks-analysis/nectar-lifesci", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "14.39", "chg": -0.75, "chgp": "-4.95%", "dir": -1, "prev_price": "15.14", "mcapval": "326.00 Cr", "mcap": "Micro Cap", "scripcode": 532649, "symbol": "NECLIFE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE023H01027", "curr_date": "Jan 19", "curr_time": "", "bse_nse_vol": "10.1 lacs", "exc_status": "Active", "traded_date": "Jan 19, 2026", "traded_date_str": "2026 01 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nectar-lifesci-216478-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Nectar Lifescience Ltd Hits Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3794716", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NectarLifescien_stocks_hitting_lower_circuit_3794716.png", "date": "2026-01-19 15:00:08", "description": "Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 19 Jan 2026, culminating in the stock hitting its lower circuit limit. The share price plunged by 4.95% to close at ₹14.39, marking the maximum permissible daily loss and reflecting mounting investor concerns amid a sustained downtrend." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-3791844", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NectarLifescien_mojoScore_3791844.png", "date": "2026-01-14 10:10:21", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Nectar Lifescience Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3791621", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NectarLifescien_stocks_hitting_lower_circuit_3791621.png", "date": "2026-01-14 10:00:08", "description": "Nectar Lifescience Ltd (NSE: BE) plunged to its lower circuit price limit on 14 Jan 2026, closing at ₹15.58 after a sharp decline of 4.94% in a single session. The stock’s fall reflects intense selling pressure and panic among investors, marking a continuation of a six-day losing streak that has eroded over 20% of its value in recent trading." }, { "title": "Nectar Lifescience Ltd Hits Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3786820", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NectarLifescien_stocks_hitting_lower_circuit_3786820.png", "date": "2026-01-09 10:00:08", "description": "Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 9 Jan 2026, hitting its lower circuit limit. The stock closed at ₹18.65, down 0.16% on the day, marking a continuation of a three-day losing streak that has eroded nearly 5% of its value. This sharp decline reflects mounting investor concerns amid dwindling participation and unfilled supply, signalling a potential shift in market sentiment for the company." }, { "title": "Nectar Lifescience Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3782012", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NectarLifescien_stocks_hitting_lower_circuit_3782012.png", "date": "2026-01-05 12:00:07", "description": "Nectar Lifescience Ltd, a micro-cap pharmaceutical company, witnessed intense selling pressure on 5 Jan 2026, triggering the stock to hit its lower circuit limit. The share price plummeted by 5.41%, closing at ₹19.12, marking a maximum daily loss that reflects mounting investor concerns and unfilled supply in the market." }, { "title": "Nectar Lifescience Gains 0.05%: 3 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-gains-005-3-key-factors-driving-the-weeks-volatility-3780238", "imagepath": "", "date": "2026-01-04 16:58:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>29 Dec:</strong> New lower circuit hit amid heavy selling pressure (₹19.09)</p>\n <p><strong>31 Dec:</strong> Upper circuit surge to ₹19.41 on strong buying interest</p>\n <p><strong>1 Jan:</strong> Another upper circuit hit at ₹20.38, signalling bullish momentum</p>\n <p><strong>2 Jan:</strong> Slight pullback to ₹20.15, closing the week flat</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.20.14</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=..." }, { "title": "Nectar Lifescience Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-3779959", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NectarLifescien_mojoScore_3779959.png", "date": "2026-01-03 10:10:05", "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Nectar Lifescience Ltd Surges to Upper Circuit Amid Robust Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3777634", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NectarLifescien_stocks_hitting_upper_circuit_3777634.png", "date": "2026-01-01 12:00:10", "description": "Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 1 Jan 2026, registering a maximum daily gain of 5.0%. This sharp price movement was driven by robust buying interest, resulting in a significant spike in trading volumes and a regulatory freeze on further transactions, underscoring intense demand for the stock." }, { "title": "Nectar Lifescience Ltd Surges to Upper Circuit Amid Robust Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nectar-lifescience-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3776560", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NectarLifescien_stocks_hitting_upper_circuit_3776560.png", "date": "2025-12-31 15:00:09", "description": "Nectar Lifescience Ltd surged to hit its upper circuit limit on 31 Dec 2025, closing at ₹19.41, marking a maximum daily gain of 4.98%. This sharp rally was driven by robust buying interest, with the stock outperforming its Pharmaceuticals & Biotechnology sector peers and the broader Sensex. Despite a recent four-day decline, the stock reversed trend decisively, signalling renewed investor confidence amid subdued liquidity and regulatory trading restrictions." } ], "total": 565, "sid": "216478", "stock_news_url": "https://www.marketsmojo.com/news/nectar-lifescience-216478" }, "announcements": [ { "details": "Nectar Lifesciences Limited has informed the Exchange regarding Disclosure of related party transactions for the half year ended on September 30, 2019.", "source": "NSE", "caption": "Nectar Lifesciences Limited - Other General Purpose", "datetime": "21-Nov-2019" }, { "details": "Nectar Lifesciences Limited has informed the Exchange regarding 'Newspaper Publication of Financial Results'.", "source": "NSE", "caption": "Nectar Lifesciences Limited - Updates", "datetime": "15-Nov-2019" }, { "details": "Nectar Lifesciences Limited has informed the Exchange regarding 'Publication of Notice of Board Meeting'.", "source": "NSE", "caption": "Nectar Lifesciences Limited - Updates", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Nectar Lifescience Ltd has declared <strong>5%</strong> dividend, ex-date: 11 Sep 20", "dt": "2020-09-11", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Nectar Lifescience Ltd has announced <strong>1:10</strong> stock split, ex-date: 12 Nov 08", "dt": "2008-11-12", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

29 Dec: New lower circuit hit amid heavy selling pressure (₹19.09)

31 Dec: Upper circuit surge to ₹19.41 on strong buying interest

1 Jan: Another upper circuit hit at ₹20.38, signalling bullish momentum

2 Jan: Slight pullback to ₹20.15, closing the week flat

Week Open

Rs.20.14

Week Close

Read full news article

Nectar Lifescience Ltd is Rated Strong Sell

2026-01-03 10:10:05

Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Nectar Lifescience Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2026-01-01 12:00:10

Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 1 Jan 2026, registering a maximum daily gain of 5.0%. This sharp price movement was driven by robust buying interest, resulting in a significant spike in trading volumes and a regulatory freeze on further transactions, underscoring intense demand for the stock.

Read full news article

Nectar Lifescience Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2025-12-31 15:00:09

Nectar Lifescience Ltd surged to hit its upper circuit limit on 31 Dec 2025, closing at ₹19.41, marking a maximum daily gain of 4.98%. This sharp rally was driven by robust buying interest, with the stock outperforming its Pharmaceuticals & Biotechnology sector peers and the broader Sensex. Despite a recent four-day decline, the stock reversed trend decisively, signalling renewed investor confidence amid subdued liquidity and regulatory trading restrictions.

Read full news article